(Q44469967)

3 December 2017

title

Low nevirapine plasma concentrations predict virological failure in an unselected HIV-1-infected population (English)

1 reference

3 December 2017

1 reference

5

Jos H Beijnen

1 reference

3 December 2017

Theodora de Vries-Sluijs

series ordinal

1

object named as

Theodora E M S de Vries-Sluijs

1 reference

3 December 2017

6

Martin Schutten

1 reference

3 December 2017

Marchina E. van der Ende

series ordinal

7

object named as

Marchina E van der Ende

1 reference

3 December 2017

4

Alwin D R Huitema

1 reference

3 December 2017

Jeanne P Dieleman

2

1 reference

3 December 2017

Dennis Arts

series ordinal

3

1 reference

3 December 2017

publication date

1 January 2003

1 reference

Clinical Pharmacokinetics

3 December 2017

published in

1 reference

3 December 2017

volume

42

1 reference

3 December 2017

issue

6

1 reference

3 December 2017

page(s)

599-605

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200342060-00009

3 December 2017

exact match

0 references

cites work

Experience with nevirapine in previously treated HIV-1-infected individuals

1 reference

12 December 2020

Limited sampling strategies for the estimation of the systemic exposure to the HIV-1 nonnucleoside reverse transcriptase inhibitor nevirapine

1 reference

12 December 2020

Treatment failure of nelfinavir-containing triple therapy can largely be explained by low nelfinavir plasma concentrations

1 reference

12 December 2020

High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study.

1 reference

12 December 2020

Study finds AIDS patients live longer when their doctors have more experience treating HIV

1 reference

12 December 2020

The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals

1 reference

12 December 2020

The effect of plasma drug concentrations on HIV-1 clearance rate during quadruple drug therapy.

1 reference

12 December 2020

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

1 reference

12 December 2020

Rapid determination of nevirapine in human plasma by ion-pair reversed-phase high-performance liquid chromatography with ultraviolet detection

1 reference

12 December 2020

Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study

1 reference

12 December 2020

Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.

1 reference

12 December 2020

Low plasma concentrations of indinavir are related to virological treatment failure in HIV-1-infected patients on indinavir-containing triple therapy

1 reference

12 December 2020

The VIRGO study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults

1 reference

12 December 2020

High-dose nevirapine in previously untreated human immunodeficiency virus type 1-infected persons does not result in sustained suppression of viral replication

1 reference

12 December 2020

High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals

1 reference

12 December 2020

The effect of nevirapine in combination with nelfinavir in heavily pretreated HIV-1-infected patients: a prospective, open-label, controlled, randomized study

1 reference

12 December 2020

[Treatment adherence amongst HIV-infected patients in Rotterdam: poorer prognosis independent of nationality in heterosexual infected patients, intravenous drug users, Negroid and Latin-American patients]

1 reference

12 December 2020

10.2165/00003088-200342060-00009

Identifiers

DOI

1 reference

Dimensions Publication ID

3 December 2017

1044302025

0 references

1 reference